Genprex Inc Share Price Today: Live Updates & Key Insights

Genprex Inc share price today is $1.85, up -2.08%. The stock opened at $1.95 against the previous close of $1.92, with an intraday high of $1.95 and low of $1.846.

Genprex Inc Share Price Chart

Genprex Inc

us-stock
To Invest in {{usstockname}}
us-stock

Genprex Inc Share Price Performance

$1.85 -0.0208(-2.08%) GNPX at 23 Mar 2026 01:21 PM Biotechnology
Lowest Today 1.846
Highest Today 1.95
Today’s Open 1.95
Prev. Close 1.92
52 Week High 55.00
52 Week Low 1.71
Day’s Range: Low 1.846 High 1.95
52-Week Range: Low 1.71 High 55.00
1 day return -
1 Week return -10.14
1 month return -18.42
3 month return -7.0
6 month return +720.1
1 year return +399.32
3 year return -94.26
5 year return -99.07
10 year return -

Genprex Inc Institutional Holdings

Abante Quant Value FI 0.60

Vanguard Institutional Extnd Mkt Idx Tr 0.30

Fidelity Extended Market Index 0.26

Tower Research Capital LLC 0.17

UBS Group AG 0.17

Fidelity Series Total Market Index 0.08

MILLER WEALTH ADVISORS, LLC 0.06

Cheviot Value Management, Inc. 0.05

Spartan Total Market Index Pool G 0.05

Fidelity Total Market Index 0.04

Advisor Group Holdings, Inc. 0.01

BlackRock Inc 0.01

Citigroup Inc 0.01

SBI Securities Co Ltd 0.00

EC SICAV EverCapital Invms UCITS I Ins I 0.00

NT Ext Equity Mkt Idx Fd - NL 0.00

Morgan Stanley - Brokerage Accounts 0.00

NT Ext Equity Mkt Idx Fd - L 0.00

Northern Trust Extended Eq Market Idx 0.00

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.00

Bank of America Corp 0.00

BNYM Mellon SL Market Completion UC1 0.00

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.00

State St US Extended Mkt Indx NL Cl C 0.00

FMR Inc 0.00

Hanson Mcclain Inc 0.00

NT US Market Cap Idx Fd - L 0.00

SSgA U.S. Total Market Index Strategy 0.00

State St US Ttl Mkt Indx NL Cl A 0.00

BNYM Mellon NSL Mkt Completion Fund Inst 0.00

Danske Bank A/S. 0.00

Fidelity U.S. Equity Index Ins Trust 0.00

Global Retirement Partners, LLC. 0.00

Group One Trading, LP 0.00

Northern Trust Wilshire 5000 0.00

Royal Bank of Canada 0.00

Capital Advisors, Ltd. LLC 0.00

CURIO WEALTH, LLC 0.00

JPMorgan Chase & Co 0.00

Susquehanna International Group, LLP 0.00

Genprex Inc Market Status

Strong Buy: 1

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

Genprex Inc Fundamentals

Market Cap 6.76 M

PB Ratio 5.559

PE Ratio 0.0974

Enterprise Value 3.16 M

Total Assets 4.12 M

Volume 252798

Genprex Inc Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:-23830719 -23.8M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-31454808 -31.5M, FY22:-29463105 -29.5M, FY21:-19590491 -19.6M, FY20:-17923959 -17.9M, FY19:-10654768 -10.7M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:9916 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:null 0.0M, Q1/2025:-463 -0.0M, Q3/2024:null 0.0M, Q2/2024:-2288 -0.0M

Quarterly Net worth Q3/2025:-3799240 -3.8M, Q2/2025:-4674901 -4.7M, Q1/2025:-3964601 -4.0M, Q3/2024:-4315987 -4.3M, Q2/2024:-6495845 -6.5M

About Genprex Inc & investment objective

Company Information Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's lead product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC. Its three-lung cancer clinical programs have received a Fast Track Designation from the FDA for the treatment of that patient population, and SCLC program has received an FDA Orphan Drug Designation. The company's diabetes gene therapy comprises of a novel infusion process that uses an AAV vector to deliver Pdx1 and MafA genes directly to the pancreas. In models of Type 1 diabetes, its GPX-002 transforms alpha cells in the pancreas into functional beta-like cells, which produce insulin but distinct enough from beta cells to evade the body's immune system; and GPX-002 for Type 2 diabetes, where autoimmunity is not at play, is believed to rejuvenate and replenish exhausted beta cells. It has research agreement with The University of Michigan Rogel Cancer Center and Lung Cancer Study Collaboration with ALK Positive. Genprex, Inc. was incorporated in 2009 and is based in Austin, Texas.

Organisation Biotechnology

Employees 13

Industry Biotechnology

CEO Mr. Ryan M. Confer M.S.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Genprex Inc FAQs

What is the share price of Genprex Inc today?

The current share price of Genprex Inc is $1.85.

Can I buy Genprex Inc shares in India?

Yes, Indian investors can buy Genprex Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Genprex Inc shares in India?

You can easily invest in Genprex Inc shares from India by:

Can I buy fractional shares of Genprex Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Genprex Inc?

Genprex Inc has a market cap of $6.76 M.

In which sector does Genprex Inc belong?

Genprex Inc operates in the Biotechnology sector.

What documents are required to invest in Genprex Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Genprex Inc?

The PE ratio of Genprex Inc is 0.10 and the PB ratio is 5.56.